17.94USD+1.07%Mkt Cap: 1.88B USDP/E: 50.96Last update: 2026-06-01
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.88B USD
Enterprise Value2.28B USD
Revenue (TTM)2.18B USD
Gross Profit1.36B USD
Net Income (TTM)-713.41M USD
Revenue/Share21.41 USD
Last Price17.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees835
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS8036071004
Valuation
P/E (Trailing)50.96
P/E (Forward)6.56
PEG-0.09
EV/EBITDA49.38
EV/Revenue1.04
P/S0.86
P/B1.25
EPS (TTM)0.35
EPS (Forward)2.73
52W Range
10.4222% of range43.92
52W High43.92 USD
52W Low10.42 USD
Profitability
Gross Margin61.81%
Oper. Margin49.05%
EBITDA Margin2.11%
Profit Margin-32.45%
ROE-62.55%
ROA-21.30%
Growth
Revenue Growth-1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-205.48M USD
CapEx (TTM)109.85M USD
FCF Margin9.38%
FCF Yield10.88%
Net Debt393.86M USD
Net Debt/EBITDA8.53
Balance Sheet
Debt/Equity0.91
Current Ratio4.63
Quick Ratio2.41
Book Value/Sh14.26 USD
Cash/Share6.187 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateJul 12, 2012
Analyst Consensus
Rating2.8 (Hold)
Target (Mean)22.00 USD
Target Range5.000 USD – 38.00 USD
# Analysts23
Ownership
Shares Out.105.58M
Float94.80M
Insiders4.09%
Institutions99.09%
Short Interest
Short Ratio8.4d
Short % Float28.41%
Short % Out.23.70%
Shares Short25.02M
Short (prev mo.)25.33M
Technical
SMA 5020.07 (-10.6%)
SMA 20019.97 (-10.1%)
Beta0.26
S&P 52W Chg27.70%
Avg Vol (30d)2.79M
Avg Vol (10d)2.85M
Technical Indicators
RSI (14)42.6
MACD-0.9765
MACD Signal-0.8948
MACD Hist.-0.0817
BB Upper22.95 USD
BB Middle18.78 USD
BB Lower14.62 USD
BB Width44.34%
ATR (14)0.9061 USD
Vol Ratio (20d)0.60x